ArcBest Corp

ARCB has rolled over from its mid-year highs and is now consolidating below its intermediate EMA and SMA levels, signaling medium-term distribution. Price action below the 9/20 EMA cluster and under the 50-day SMA suggests bearish asymmetry, despite oversold range status offering potential for relief. The secular uptrend remains supported by the rising 200-day SMA, but inability to hold near-term EMAs keeps downside risk elevated toward 200-day support. A sustained move back above the ~137-138 EMA zone would reduce bearish risk; failing that, further declines toward the 200-day SMA would confirm deeper correction.

• ↑Q2 revenue grew 16% YoY to $1.2 billion, capturing market share
• ↑Adjusted EPS reached $2.38 vs. $1.36 YoY; analysts now expect $6.90 in 2026
• ↓Operating ratio increased to 96.2% and may rise another 400 bps in Q4